Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide.
Hathaway JT, Shah MP, Hathaway DB, Zekavat SM, Krasniqi D, Gittinger JW Jr, Cestari D, Mallery R, Abbasi B, Bouffard M, Chwalisz BK, Estrela T, Rizzo JF 3rd.
JAMA Ophthalmol. 2024 Aug 1;142(8):732-739. doi: 10.1001/jamaophthalmol.2024.2296.
Wolfram Syndrome: Diagnosis, Management, and Treatment.
Urano F.
Curr Diab Rep. 2016 Jan;16(1):6. doi: 10.1007/s11892-015-0702-6.
Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy.
Cai CX, Hribar M, Baxter S, Goetz K, Swaminathan SS, Flowers A, Brown EN, Toy B, Xu B, Chen J, Chen A, Wang S, Lee C, Leng T, Ehrlich JR, Barkmeier A, Armbrust KR, Boland MV, Dorr D, Boyce D, Alshammari T, Swerdel J, Suchard MA, Schuemie M, Bu F, Sena AG, Hripcsak G, Nishimura A, Nagy P, Falconer T, DuVall SL, Matheny M, Viernes B, O'Brien W, Zhang L, Martin B, Westlund E, Mathioudakis N, Fan R, Wilcox A, Lai A, Stocking JC, Takkouche S, Lee LH, Xie Y, Humes I, McCoy DB, Adibuzzaman M, Areaux RG Jr, Rojas-Carabali W, Brash J, Lee DA, Weiskopf NG, Mawn L, Agrawal R, Morgan-Cooper H, Desai P, Ryan PB.
JAMA Ophthalmol. 2025 Apr 1;143(4):304-314. doi: 10.1001/jamaophthalmol.2024.6555.
The Effect of Semaglutide and GLP-1 RAs on Risk of Nonarteritic Anterior Ischemic Optic Neuropathy.
Abbass NJ, Nahlawi R, Shaia JK, Allan KC, Kaelber DC, Talcott KE, Singh RP.
Am J Ophthalmol. 2025 Jun;274:24-31. doi: 10.1016/j.ajo.2025.02.025. Epub 2025 Feb 25.
Once-weekly semaglutide doubles the five-year risk of nonarteritic anterior ischemic optic neuropathy in a Danish cohort of 424,152 persons with type 2 diabetes.
Grauslund J, Taha AA, Molander LD, Kawasaki R, Möller S, Højlund K, Stokholm L.
Int J Retina Vitreous. 2024 Dec 18;10(1):97. doi: 10.1186/s40942-024-00620-x.
Ophthalmic Complications Associated With the Antidiabetic Drugs Semaglutide and Tirzepatide.
Katz BJ, Lee MS, Lincoff NS, Abel AS, Chowdhary S, Ellis BD, Najafi A, Nguyen J, Seay MD, Warner JEA.
JAMA Ophthalmol. 2025 Mar 1;143(3):215-220. doi: 10.1001/jamaophthalmol.2024.6058.
Semaglutide and non-arteritic anterior ischaemic optic neuropathy: Review and interpretation of reported association.
Amini A, Hamann S, Larsen M.
Acta Ophthalmol. 2025 Sep;103(6):615-621. doi: 10.1111/aos.17473. Epub 2025 Mar 8.
Association between Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy: A Multinational Population-Based Study.
Chou CC, Pan SY, Sheen YJ, Lin JF, Lin CH, Lin HJ, Wang IJ, Weng CH.
Ophthalmology. 2025 Apr;132(4):381-388. doi: 10.1016/j.ophtha.2024.10.030. Epub 2024 Nov 2.
An update on ocular effects of antidiabetic medications.
Sadeghi E, Rahmanipour E, Valsecchi N, Kapoor S, Cicinelli MV, Chhablani J.
Surv Ophthalmol. 2025 Jul-Aug;70(4):704-712. doi: 10.1016/j.survophthal.2025.01.010. Epub 2025 Jan 22.
Association of Glucagon-Like Peptide-1 Receptor Agonists With Optic Nerve and Retinal Adverse Events: A Population-Based Observational Study Across 180 Countries.
Lakhani M, Kwan ATH, Mihalache A, Popovic MM, Nanji K, Xie JS, Feo A, Rabinovitch D, Shor R, Sadda S, Sarraf D, Hurley B, Margolin EA, Kertes PJ, Chaudhary V, Muni RH.
Am J Ophthalmol. 2025 Sep;277:148-168. doi: 10.1016/j.ajo.2025.05.007. Epub 2025 May 16.
